StonvexLoading…
StonvexStonvexStonvexCore line items from BCRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $874.84M | $450.71M | $331.41M | $270.83M |
Operating Income | $340.99M | $-2.54M | $-103.71M | $-148.44M |
Net Income | $263.86M | $-88.88M | $-226.54M | $-247.12M |
EPS (Diluted) | $1.21 | $-0.43 | $-1.18 | $-1.33 |
Total Assets | $514.16M | $490.42M | $516.96M | $550.00M |
Total Liabilities | $633.31M | $966.35M | $972.49M | Not available |
Cash & Equivalents | $89.74M | $104.71M | $110.64M | $304.77M |
Free Cash Flow OCF − CapEx | $344.90M | $-53.14M | $-97.31M | $-163.20M |
Shares Outstanding | 213.06M | 208.54M | 205.77M | 187.91M |